Switch to literature list
Chronic Venous Disease

Helping you every step of the way

One of the greatest challenges facing today’s medical professionals in managing chronic venous disease (CVD) are complex healthcare systems. A patient may endure many therapy phases, especially when the therapy process is complicated by underlying diseases or other health issues. Several specialists could be seen throughout the course of therapy. Different products and brands are all considered and tried until progress is seen. Instead of focussing on single products, imagine a new culture anchored on therapy-driven healing solutions, with the patient at the centre. Imagine a family of best-in-class, synchronised products specifically designed to ensure seamless therapy progression and give back to your patients the quality of life they desire and deserve.

  • What is CVD?

    A chronic disease, a chronic burden

    Chronic Venous Disease (CVD) is a common condition consisting of persistent morphological and functional abnormalities of the venous system (e.g. varicose veins) indicating the need for investigation and care. Chronic Venous Insufficiency (CVI) is a term reserved for advanced CVD, which includes debilitating complications such as chronic oedema, skin changes and venous leg ulcers (VLU)1. All of these can significantly impact an individual’s mobility, daily activities and quality of life.2,3

  • Where CVD happens

    Peripheral venous system of the leg

    Chronic venous disease is directly related to the health of the peripheral venous system in the legs, which consists of the deep veins, the superficial veins and perforating veins. Deoxygenated blood travels through this system into the inferior vena cava and back to the heart.

  • Where CVD happens

    Damaged venous valves - Pathogenesis

    The peripheral venous system is naturally at an overall low pressure. Venous valves can weaken for a variety of reasons such as a late consequence of deep vein thrombosis, hormonal changes during pregnancy, or a sedentary lifestyle.

    When venous valves weaken or there are abnormalities in the venous walls, blood can flow backward and increases the pressure in the peripheral venous system, known as venous hypertension. If venous hypertension is sustained over time the vein walls stretch and the valve cusps no longer meet when the valves close. This further increases the hypertension, which can lead to swelling, discomfort and varicose veins. If the increased blood pressure and symptoms are not addressed, chronic venous insufficiency can develop.

  • A chronic disease,
    a chronic burden

    A population at risk

    Today’s more sedentary lifestyles and an ageing population puts many individuals at risk of CVD, leading to increasing CVD-related costs for healthcare systems worldwide. Family history and certain comorbidities further increase the risk to develop CVD.

  • A chronic disease,
    a chronic burden

    A population at risk

    The risk factors:

    • Over 50 years of age
    • Tall
    • Limited mobility
    • Pregnancy
    • Obesity
    • Sitting/standing for long periods
    • Medications that cause/increase oedema4
    • Family history of varicose veins, venous ulcers or deep vein thrombosis2
    • Multiple chronic comorbidities that damage the venous system such as cardiac failure, diabetes, phlebitis, venous thrombosis and venous obstruction4
  • A chronic disease,
    a chronic burden

    A serious burden on healthcare systems

    • More than 50% of venous ulcers require therapy longer than a year2, and 70% of venous leg ulcers can recur5
    • Nearly 5% of the adult population in developed countries is affected by CVD6
    • 5-30% of the population is affected by varicose veins2
    • 60-80% of leg ulcers have a venous component3. Up to 1% of the Western population affected for active and healed ulcers combined7
    • Annually, nearly 2% of total health care costs in the US and Europe are attributed to the therapy of chronic wounds; venous leg ulcer care is estimated at $3 billion annually2, 8, 9
    • The estimated cost of venous leg ulcer treatment in the USA is $2,500 per patient, per year - in Germany it is €9,750 per patient, per year
  • What is CVD?

    A chronic disease, a chronic burden

    Chronic Venous Disease (CVD) is a common condition consisting of persistent morphological and functional abnormalities of the venous system (e.g. varicose veins) indicating the need for investigation and care. Chronic Venous Insufficiency (CVI) is a term reserved for advanced CVD, which includes debilitating complications such as chronic oedema, skin changes and venous leg ulcers (VLU)1. All of these can significantly impact an individual’s mobility, daily activities and quality of life.2,3

  • Where CVD happens

    Peripheral venous system of the leg

    Chronic venous disease is directly related to the health of the peripheral venous system in the legs, which consists of the deep veins, the superficial veins and perforating veins. Deoxygenated blood travels through this system into the inferior vena cava and back to the heart.

  • Where CVD happens

    Damaged venous valves - Pathogenesis

    The peripheral venous system is naturally at an overall low pressure. Venous valves can weaken for a variety of reasons such as a late consequence of deep vein thrombosis, hormonal changes during pregnancy, or a sedentary lifestyle.

    When venous valves weaken or there are abnormalities in the venous walls, blood can flow backward and increases the pressure in the peripheral venous system, known as venous hypertension. If venous hypertension is sustained over time the vein walls stretch and the valve cusps no longer meet when the valves close. This further increases the hypertension, which can lead to swelling, discomfort and varicose veins. If the increased blood pressure and symptoms are not addressed, chronic venous insufficiency can develop.

  • A chronic disease, a chronic burden

    A population at risk

    Today’s more sedentary lifestyles and an ageing population puts many individuals at risk of CVD, leading to increasing CVD-related costs for healthcare systems worldwide. Family history and certain comorbidities further increase the risk to develop CVD.

  • A chronic disease, a chronic burden

    A population at risk

    The risk factors:

    • Over 50 years of age
    • Tall
    • Limited mobility
    • Pregnancy
    • Obesity
    • Sitting/standing for long periods
    • Medications that cause/increase oedema4
    • Family history of varicose veins, venous ulcers or deep vein thrombosis2
    • Multiple chronic comorbidities that damage the venous system such as cardiac failure, diabetes, phlebitis, venous thrombosis and venous obstruction4
  • Where CVD happens

    A serious burden on healthcare systems

    • More than 50% of venous ulcers require therapy longer than a year1, and 70% of venous leg ulcers can recur5
    • Nearly 5% of the adult population in developed countries is affected by CVD6
    • 5-30% of the population is affected by varicose veinsi2
    • 60-80% of leg ulcers have a venous component3. Up to 1% of the Western population affected for active and healed ulcers combined7
    • Annually, nearly 2% of total health care costs in the US and Europe are attributed to the therapy of chronic wounds; venous leg ulcer care is estimated at $3 billion annually2, 8, 9
    • The estimated cost of venous leg ulcer treatment in the USA is $2,500 per patient, per year - in Germany it is €9,750 per patient, per year
  • Elements of comprehensive patient assessment

    Patient´s clinical history

    • Assessment of patient´s clinical history, noting any other chronic conditions that could complicate management or limit options.
    • Collection of additional patient data such as age, dexterity and any disabilities or mobility issues that could affect therapy options, application and patient compliance.
    • Identifiction of any possible allergic reactions to any compression or wound care materials.
  • Elements of comprehensive patient assessment

    Physical examination

    • Inspection of skin for irregularities and vulnerable areas, such as active or newly healed ulcers, irritation or dryness, and stress from oedema.
    • Determination if abnormal venous back flow is present and measurement of ankle brachial pressure index (ABPI) with a hand-held Doppler ultrasound device and blood pressure cuff.
    • Investigation for any valve failure or vein dysfunction via venous duplex imaging.
  • The path towards therapy

    The first steps towards treating CVD are assessing etiology (venous, arterial or mixed) and severity of the insufficiency and classifying your patient’s symptoms. A well-established clinical classification system known as CEAP - Clinical, Etiology, Anatomic and Pathophysiology - was developed in 1994 by an international consensus conference to provide uniformity in reporting, diagnosis and treating CVD.

  • Elements of comprehensive patient assessment

    Patient´s clinical history

    • Assessment of patient´s clinical history, noting any other chronic conditions that could complicate management or limit options.
    • Collection of additional patient data such as age, dexterity and any disabilities or mobility issues that could affect therapy options, application and patient compliance.
    • Identifiction of any possible allergic reactions to any compression or wound care materials.
  • Elements of comprehensive patient assessment

    Physical examination

    • Inspection of skin for irregularities and vulnerable areas, such as active or newly healed ulcers, irritation or dryness, and stress from oedema.
    • Determination if abnormal venous back flow is present and measurement of ankle brachial pressure index (ABPI) with a hand-held Doppler ultrasound device and blood pressure cuff.
    • Investigation for any valve failure or vein dysfunction via venous duplex imaging.
  • The path towards therapy

    The first steps towards treating CVD are assessing etiology (venous, arterial or mixed) and severity of the insufficiency and classifying your patient’s symptoms. A well-established clinical classification system known as CEAP - Clinical, Etiology, Anatomic and Pathophysiology - was developed in 1994 by an international consensus conference to provide uniformity in reporting, diagnosis and treating CVD.

  • CEAP Classification

    CVD can be classified according to the severity, cause, site and specific abnormality using the CEAP classification. Use of such a classification improves the accuracy of the diagnosis and improves communication between specialists. The elements of the CEAP classification are: Clinical condition, Etiology or cause, Anatomic location and Pathophysiology.

  • The Development of CVD

    CEAP C0 - Out of sight but developing

    C0 is easily missed, because there are no visual or clinical indicators. Patients might complain of tired, heavy legs but attribute it to standing for long periods. At this stage, preventative care can have an excellent outcome. If your patient has several of the factors, it is recommended to begin dialogue about the disease, stressing the importance of preventing progression and the consequences of leaving it untreated. Emphasis on early therapy for maximising quality of life is recommended.

  • The Development of CVD

    CEAP C1 - Signs are beginning to appear

    As the venous system begins to experience valve failure, the first visual indicator might be telangiectasia or reticular veins ("spider veins"). As with CEAP C0, patients may also complain of tired, heavy legs and could experience some minor swelling, which resolves with leg elevation or rest. Since spider veins are mostly viewed as a cosmetic issue by patients, discussion about the risks and pain associated with the more ugly varicose veins, the next progression from this stage, could motivate a patient to take action to slow down disease progression.

  • The Development of CVD

    CEAP C2 – Time to get serious

    In C2 the most significant indicator of CVD are varicose veins. Venous valve failure is serious enough that back flow and blood pooling are causing vein walls to stretch beyond repair. Complaints of tired, heavy, painful legs and minor swelling are common. The patient might address unsightly or painful varicose veins out of concern for underlying causes. Like spider veins, varicose veins are also often viewed as cosmetic and simply part of ageing. It is critical patients understand that once CVD begins to transition to CEAP C3, delivery of nutrients and oxygen to the skin is being compromised and complications can easily develop. Dialogue at this stage should include the specific risks to skin health should CVD be allowed to progress to C3 and C4.

  • The Development of CVD

    CEAP C3 – Increasing patient discomfort

    At C3, the primary symptoms are oedema. Caused by venous blood and blood protein in lower extremity tissues, the oedema is firm and fibrous to the touch and is often accompanied by a heavy ache that is both deep and dull. There are no trophic changes to the skin, but therapy is critical to counteract more severe symptoms such as skin ulceration and other chronic manifestations associated with progression to the later stages of CVD. Compression therapy stockings and bandages help support the calf muscle to pump blood preventing back flow and pooling in superficial veins. Both options help reduce capillary filtration and increase interstitial compression, which helps excess fluid to be absorbed back into the venous and lymphatic system, reducing oedema. At C3, a higher compression class would be beneficial to achieve desired outcomes.

  • The Development of CVD

    CEAP C4 – Serious risk of progression

    At CEAP C4 skin changes are present. Atrophie blanche, purpuric dermatitis and varicose eczema may also develop. There is also great risk for lipodermatosclerosis. Once this is present, the skin is irreversibly damaged and the therapy goal is to prevent further progression to venous leg ulcer (VLU) (C6) and other complications such as chronic ulceration or infection. Because the skin is now quite fragile, extra care must be taken to not cause trauma through friction, for example scratching the skin. It is critical for patients to understand how vital it is to delay progression, as well as having a clear perspective on what could lie ahead should the disease progress. Managing a patient’s expectations about quality of life, any current limitations and duration of therapy will help ensure very necessary compliance.

  • The Development of CVD

    CEAP C5 – The road to venous leg ulcer (VLU) recovery

    Though C5 is evidenced by healed ulcers as other serious CVD conditions might still exist, there is a 70% chance of recurrence of a VLU and the patient re-entering C6. VLUs can be complicated, requiring a lengthy healing process. Because treating a chronic VLU can also mean managing high wound exudate levels, malodour, any infection or infection risk, a patient’s mobility, morale and general sense of well-being can be negatively affected. During C5, educating your patient on keeping the skin healthy as part of an overall ulcer prevention plan is key.

  • The Development of CVD

    CEAP C6 – The road to venous leg ulcer (VLU) recovery

    During the challenges of C6, helping your patient understand the healing process and why it sometimes takes longer than expected can help manage patient expectations. At the same time, it is important to also offer patients hope that chronic VLU’s can be healed by carefully and diligently complying to combined wound care and compression therapy plans.

  • CEAP Classification

    CVD can be classified according to the severity, cause, site and specific abnormality using the CEAP classification. Use of such a classification improves the accuracy of the diagnosis and improves communication between specialists. The elements of the CEAP classification are: Clinical condition, Etiology or cause, Anatomic location and Pathophysiology.

  • The Development of CVD

    CEAP C0 - Out of sight but developing

    C0 is easily missed, because there are no visual or clinical indicators. Patients might complain of tired, heavy legs but attribute it to standing for long periods. At this stage, preventative care can have an excellent outcome. If your patient has several of the factors, it is recommended to begin dialogue about the disease, stressing the importance of preventing progression and the consequences of leaving it untreated. Emphasis on early therapy for maximising quality of life is recommended.

  • The Development of CVD

    CEAP C1 - Signs are beginning to appear

    As the venous system begins to experience valve failure, the first visual indicator will be telangiectasia or reticular veins ("spider veins"). As with CEAP C0, patients may also complain of tired, heavy legs and could experience some minor swelling, which resolves with leg elevation or rest. Since spider veins are mostly viewed as a cosmetic issue by patients, discussion about the risks and pain associated with the more ugly varicose veins, the next progression from this stage, could motivate a patient to take action to slow down disease progression.

  • The Development of CVD

    CEAP C2 – Time to get serious

    In C2 the most significant indicator of CVD are varicose veins. Venous valve failure is serious enough that back flow and blood pooling are causing vein walls to stretch beyond repair. Complaints of tired, heavy, painful legs and minor swelling are common. The patient might address unsightly or painful varicose veins out of concern for underlying causes. Like spider veins, varicose veins are also often viewed as cosmetic and simply part of ageing. It is critical patients understand that once CVD begins to transition to CEAP C3, delivery of nutrients and oxygen to the skin is being compromised and complications can easily develop. Dialogue at this stage should include the specific risks to skin health should CVD be allowed to progress to C3 and C4.

  • The Development of CVD

    CEAP C3 – Increasing patient discomfort

    At C3, the primary symptoms are oedema. Caused by venous blood and blood protein in lower extremity tissues, the oedema is firm and fibrous to the touch and is often accompanied by a heavy ache that is both deep and dull. There are no trophic changes to the skin, but therapy is critical to counteract more severe symptoms such as skin ulceration and other chronic manifestations associated with progression to the later stages of CVD. Compression therapy stockings and bandages help support the calf muscle to pump blood preventing back flow and pooling in superficial veins. Both options help reduce capillary filtration and increase interstitial compression, which helps excess fluid to be absorbed back into the venous and lymphatic system, reducing oedema. At C3, a higher compression class would be beneficial to achieve desired outcomes.

  • The Development of CVD

    CEAP C4 – Serious risk of progression

    At CEAP C4 oedema and skin changes are present. Atrophie blanche, purpuric dermatitis and varicose eczema may also develop. There is also great risk for lipodermatosclerosis. Once this is present, the skin is irreversibly damaged and the therapy goal is to prevent further progression to venous leg ulcer (VLU) (C6) and other complications such as chronic ulceration or infection. Because the skin is now quite fragile, extra care must be taken to not cause trauma through friction, for example scratching the skin. It is critical for patients to understand how vital it is to delay progression, as well as having a clear perspective on what could lie ahead should the disease progress. Managing a patient’s expectations about quality of life, any current limitations and duration of therapy will help ensure very necessary compliance.

  • The Development of CVD

    CEAP C5 – The road to venous leg ulcer (VLU) recovery

    Though C5 is evidenced by healed ulcers as other serious CVD conditions might still exist, there is a 70% chance of recurrence of a VLU and the patient re-entering C6. VLUs can be complicated, requiring a lengthy healing process. Because treating a chronic VLU can also mean managing high wound exudate levels, malodour, any infection or infection risk, a patient’s mobility, morale and general sense of well-being can be negatively affected. During C5, educating your patient on keeping the skin healthy as part of an overall ulcer prevention plan is key.

  • The Development of CVD

    CEAP C6 – The road to venous leg ulcer (VLU) recovery

    During the challenges of C6, helping your patient understand the healing process and why it sometimes takes longer than expected can help manage patient expectations. At the same time, it is important to also offer patients hope that chronic VLU’s can be healed by carefully and diligently complying to combined wound care and compression therapy plans.

BSN medical´s products for the treatment of CVD

Choose a CEAP Classification

C0
C1
C2
C3
C4
C5
C6

JOBST® UltraSheer (support compression)

JOBST® UltraSheer is the perfect hosiery for any occasion - for tired, heavy legs. It combines the sheer appeal of fine fashion garments with the durability of JOBST® quality.

JOBST® forMen

A stylish, comfortable men's sock in a design that makes it ideal for everyday work or leisure - for tired, heavy legs.

JOBST® TravelSocks

Sitting for long periods of time in the cramped quarters of an airplane, car, train or bus can lead to circulatory problems - JOBST® Travel Socks promote leg health during long hours of inactivity.

JOBST® Sport

The perfect combination of athletic styling and medically effective compression therapy: JOBST® Sport combines superior moisture management with an anatomically correct cushioned heel and foot and is ideal for any sporting activity.

JOBST® UltraSheer

Fashion and efficacy rolled all into one. JOBST® UltraSheer is the sheerest compression stocking in its class. Lightweight, comfortable and highly effective in optimizing leg health.

JOBST® Opaque

Luxuriously smooth and easy to wear, JOBST® Opaque is ultra soft for the most comfortable stocking in its class.

JOBST® forMen Ambition & Explore

JOBST® forMen Ambition is designed for the aspiring male in today's world to maximize feel, performance and comfort. The effective medical compression stocking JOBST® forMen Explore is a universal companion for strained legs at work and leisure time.

Cutimed® ACUTE

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

JOBST® TravelSocks

Sitting for long periods of time in the cramped quarters of an airplane, car, train or bus can lead to circulatory problems - JOBST® Travel Socks promote leg health during long hours of inactivity.

JOBST® Sport

The perfect combination of athletic styling and medically effective compression therapy: JOBST® Sport combines superior moisture management with an anatomically correct cushioned heel and foot and is ideal for any sporting activity.

JOBST® UltraSheer

Fashion and efficacy rolled all into one. JOBST® UltraSheer is the sheerest compression stocking in its class. Lightweight, comfortable and highly effective in optimizing leg health.

JOBST® Opaque

Luxuriously smooth and easy to wear, JOBST® Opaque is ultra soft for the most comfortable stocking in its class.

JOBST® forMen Ambition & Explore

JOBST® forMen Ambition is designed for the aspiring male in today's world to maximize feel, performance and comfort. The effective medical compression stocking JOBST® forMen Explore is a universal companion for strained legs at work and leisure time.

Comprilan®

Comprilan® is a short-stretch compression bandage to provide graduated compression for efficient oedema reduction and post-operative treatment - the frequent one, re-usable for versatile applications, where bandaging expertise is required.

JOBST® Comprifore lite

JOBST® Comprifore is the compression bandage for effective venous leg ulcer therapy - the expert for precise compression treatment where bandaging expertise is required (lite compression 20-30 mmHg).

JOBST® Compri2 lite

JOBST® Compri2 lite is the safe, efficient and cost-effective therapy solution for oedema reduction - the easy one, easy to apply and a safe solution in particular for mixed types (lite compression 20-30 mmHg).

Cutimed® Acute

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

JOBST® Sport

The perfect combination of athletic styling and medically effective compression therapy: JOBST® Sport combines superior moisture management with an anatomically correct cushioned heel and foot and is ideal for any sporting activity.

JOBST® UltraSheer

Fashion and efficacy rolled all into one. JOBST® UltraSheer is the sheerest compression stocking in its class. Lightweight, comfortable and highly effective in optimizing leg health.

JOBST® Opaque

Luxuriously smooth and easy to wear, JOBST® Opaque is ultra soft for the most comfortable stocking in its class.

JOBST® forMen Ambition & Explore

JOBST® forMen Ambition is designed for the aspiring male in today's world to maximize feel, performance and comfort. The effective medical compression stocking JOBST® forMen Explore is a universal companion for strained legs at work and leisure time.

Comprilan®

Comprilan® is a short-stretch compression bandage to provide graduated compression for efficient oedema reduction and post-operative treatment - the frequent one, re-usable for versatile applications, where bandaging expertise is required.

JOBST® Comprifore lite

JOBST® Comprifore is the compression bandage for effective venous leg ulcer therapy - the expert for precise compression treatment where bandaging expertise is required (lite compression 20-30 mmHg).

JOBST® Compri2 lite

JOBST® Compri2 lite is the safe, efficient and cost-effective therapy solution for oedema reduction - the easy one, easy to apply and a safe solution in particular for mixed types (lite compression 20-30 mmHg).

Cutimed® Acute

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

JOBST® Sport

The perfect combination of athletic styling and medically effective compression therapy: JOBST® Sport combines superior moisture management with an anatomically correct cushioned heel and foot and is ideal for any sporting activity.

JOBST® UltraSheer

Fashion and efficacy rolled all into one. JOBST® UltraSheer is the sheerest compression stocking in its class. Lightweight, comfortable and highly effective in optimizing leg health.

JOBST® Opaque

Luxuriously smooth and easy to wear, JOBST® Opaque is ultra soft for the most comfortable stocking in its class.

JOBST® forMen Ambition & Explore

JOBST® forMen Ambition is designed for the aspiring male in today's world to maximize feel, performance and comfort. The effective medical compression stocking JOBST® forMen Explore is a universal companion for strained legs at work and leisure time.

Comprilan®

Comprilan® is a short-stretch compression bandage to provide graduated compression for efficient oedema reduction and post-operative treatment - the frequent one, re-usable for versatile applications, where bandaging expertise is required.

JOBST® Comprifore

JOBST® Comprifore is the compression bandage for effective venous leg ulcer therapy - the expert for precise compression treatment where bandaging expertise is required (regular compression 40 mmHg).

JOBST® Compri2

JOBST® Compri2 is the safe, efficient and cost-effective therapy solution for oedema reduction - the easy one, easy to apply and a safe solution in particular for mixed types (regular compression 40 mmHg).

Cutimed® Acute

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

JOBST® UltraSheer

Fashion and efficacy rolled all into one. JOBST® UltraSheer is the sheerest compression stocking in its class. Lightweight, comfortable and highly effective in optimizing leg health.

JOBST® Opaque

Luxuriously smooth and easy to wear, JOBST® Opaque is ultra soft for the most comfortable stocking in its class.

JOBST® forMen Ambition & Explore

JOBST® forMen Ambition is designed for the aspiring male in today's world to maximize feel, performance and comfort. The effective medical compression stocking JOBST® forMen Explore is a universal companion for strained legs at work and leisure time.

Comprilan®

Comprilan® is a short-stretch compression bandage to provide graduated compression for efficient oedema reduction and post-operative treatment - the frequent one, re-usable for versatile applications, where bandaging expertise is required.

JOBST® Comprifore

JOBST® Comprifore is the compression bandage for effective venous leg ulcer therapy - the expert for precise compression treatment where bandaging expertise is required (regular compression 40 mmHg).

JOBST® Compri2

JOBST® Compri2 is the safe, efficient and cost-effective therapy solution for oedema reduction - the easy one, easy to apply and a safe solution in particular for mixed types (regular compression 40 mmHg).

Cutimed® Acute

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

JOBST® UltraSheer

Fashion and efficacy rolled all into one. JOBST® UltraSheer is the sheerest compression stocking in its class. Lightweight, comfortable and highly effective in optimizing leg health.

JOBST® Opaque

Luxuriously smooth and easy to wear, JOBST® Opaque is ultra soft for the most comfortable stocking in its class.

JOBST® forMen Ambition & Explore

JOBST® forMen Ambition is designed for the aspiring male in today's world to maximize feel, performance and comfort. The effective medical compression stocking JOBST® forMen Explore is a universal companion for strained legs at work and leisure time.

Comprilan®

Comprilan® is a short-stretch compression bandage to provide graduated compression for efficient oedema reduction and post-operative treatment - the frequent one, re-usable for versatile applications, where bandaging expertise is required.

JOBST® Comprifore

JOBST® Comprifore is the compression bandage for effective venous leg ulcer therapy - the expert for precise compression treatment where bandaging expertise is required (regular compression 40 mmHg).

JOBST® Compri2

JOBST® Compri2 is the safe, efficient and cost-effective therapy solution for oedema reduction - the easy one, easy to apply and a safe solution in particular for mixed types (regular compression 40 mmHg).

JOBST® UlcerCARE

JOBST® UlcerCARETM is designed for maximum patient compliance for the effective management of venous leg ulcers.

Cutimed® Gel

With its highly moisturising effect, Cutimed® Gel supports autolytic debridement as a gentle way to dissolve necrotic or sloughy tissue or to prepare wounds for surgical debridement.

Cutimed® Sorbact

Effective in the cleansing of unclean, colonised and infected wounds, Cutimed® Sorbact® is a unique antimicrobial concept that works without a chemically active agent. Instead it irreversibly binds and inactivates wound pathogens.

Cutimed® Siltec

Cutimed® Siltec has been developed to facilitate exudate management: the silicone layer provides for gentle adherence to the surrounding skin and minimum discomfort when changing the dressing, the foam core with super-absorbers ensures reliable absorption in slightly to heavily exuding wounds.

Cutimed® PROTECT

Cutimed® PROTECT spray and foam applicator provide a long-lasting protective barrier against both, external threats such as incontinence or wound fluids that impact the skin..

Cutimed® Acute

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

Comprilan®

Comprilan® is a short-stretch compression bandage to provide graduated compression for efficient oedema reduction and post-operative treatment - the frequent one, re-usable for versatile applications, where bandaging expertise is required.

JOBST® Comprifore

JOBST® Comprifore is the compression bandage for effective venous leg ulcer therapy - the expert for precise compression treatment where bandaging expertise is required (regular compression 40 mmHg).

JOBST® Compri2

JOBST® Compri2 is the safe, efficient and cost-effective therapy solution for oedema reduction - the easy one, easy to apply and a safe solution in particular for mixed types (regular compression 40 mmHg).

JOBST® UlcerCARE

JOBST® UlcerCARETM is designed for maximum patient compliance for the effective management of venous leg ulcers.

Cutimed® Gel

With its highly moisturising effect, Cutimed® Gel supports autolytic debridement as a gentle way to dissolve necrotic or sloughy tissue or to prepare wounds for surgical debridement.

Cutimed® Sorbact

Effective in the cleansing of unclean, colonised and infected wounds, Cutimed® Sorbact® is a unique antimicrobial concept that works without a chemically active agent. Instead it irreversibly binds and inactivates wound pathogens.

Cutimed® Siltec

Cutimed® Siltec has been developed to facilitate exudate management: the silicone layer provides for gentle adherence to the surrounding skin and minimum discomfort when changing the dressing, the foam core with super-absorbers ensures reliable absorption in slightly to heavily exuding wounds.

Cutimed® PROTECT

Cutimed® PROTECT spray and foam applicator provide a long-lasting protective barrier against both, external threats such as incontinence or wound fluids that impact the skin..

Cutimed® Acute

Cutimed® ACUTE foam mousse brings effective relief to those suffering from dry skin in a format convenient to apply by patients or their caregivers. Cutimed® ACUTE is available in 3 urea concentrations to manage the spectrum of dry skin conditions from mild to severe.

Therapies Hand in Hand

Together we can create a healthier future

As we look towards a healthier future for CVD patients, it is critical to recognise the key role patient education and compliance plays in ensuring that future. The more patients know about the underlying causes, risk factors and lifestyle choices for CVD, the more they can understand that reducing the symptoms of CVD is possible. And while there is no cure for CVD, being personally involved in the overall outcome can be quite empowering for patients, which could greatly influence their future quality of life.

We aim to create innovative and truly effective answers to the problems of therapy, to achieve a far greater degree of patient compliance which most importantly will lead to better outcomes. This is our most fundamental and overriding philosophy and the goal we constantly work for. This is the reason we are so committed to Integrated Therapy Solutions. We aim stand shoulder to shoulder with you and your patients and support them as they adapt to life with CVD. If you have any questions or wish to know more about CVD and our Integrated Therapy Solutions you are welcome to contact us at any time. Our team will be ready to assist you as best we can.

Contact

For more information about BSN medical and its Integrated Therapy Solutions please contact us using the form below:

Contact